Literature DB >> 25818029

APOBECs and virus restriction.

Reuben S Harris1, Jaquelin P Dudley2.   

Abstract

The APOBEC family of single-stranded DNA cytosine deaminases comprises a formidable arm of the vertebrate innate immune system. Pre-vertebrates express a single APOBEC, whereas some mammals produce as many as 11 enzymes. The APOBEC3 subfamily displays both copy number variation and polymorphisms, consistent with ongoing pathogenic pressures. These enzymes restrict the replication of many DNA-based parasites, such as exogenous viruses and endogenous transposable elements. APOBEC1 and activation-induced cytosine deaminase (AID) have specialized functions in RNA editing and antibody gene diversification, respectively, whereas APOBEC2 and APOBEC4 appear to have different functions. Nevertheless, the APOBEC family protects against both periodic viral zoonoses as well as exogenous and endogenous parasite replication. This review highlights viral pathogens that are restricted by APOBEC enzymes, but manage to escape through unique mechanisms. The sensitivity of viruses that lack counterdefense measures highlights the need to develop APOBEC-enabling small molecules as a new class of anti-viral drugs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOBEC family; Cytosine deaminases; DNA viruses; Innate immunity; Retroviruses

Mesh:

Substances:

Year:  2015        PMID: 25818029      PMCID: PMC4424171          DOI: 10.1016/j.virol.2015.03.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  241 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.

Authors:  Mario Perkovic; Stanislaw Schmidt; Daniela Marino; Rebecca A Russell; Benjamin Stauch; Henning Hofmann; Ferdinand Kopietz; Björn-Philipp Kloke; Jörg Zielonka; Heike Ströver; Johannes Hermle; Dirk Lindemann; Vinay K Pathak; Gisbert Schneider; Martin Löchelt; Klaus Cichutek; Carsten Münk
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

3.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.

Authors:  Shingo Kitamura; Hirotaka Ode; Masaaki Nakashima; Mayumi Imahashi; Yuriko Naganawa; Teppei Kurosawa; Yoshiyuki Yokomaku; Takashi Yamane; Nobuhisa Watanabe; Atsuo Suzuki; Wataru Sugiura; Yasumasa Iwatani
Journal:  Nat Struct Mol Biol       Date:  2012-09-23       Impact factor: 15.369

4.  Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.

Authors:  Renaud Mahieux; Rodolphe Suspène; Frédéric Delebecque; Michel Henry; Olivier Schwartz; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  J Gen Virol       Date:  2005-09       Impact factor: 3.891

5.  Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.

Authors:  Beth K Thielen; John P McNevin; M Juliana McElrath; Brook Vander Stoep Hunt; Kevin C Klein; Jaisri R Lingappa
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

Review 6.  Retroelements and the human genome: new perspectives on an old relation.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

7.  RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.

Authors:  Guoxin Liang; Kouichi Kitamura; Zhe Wang; Guangyan Liu; Sajeda Chowdhury; Weixin Fu; Miki Koura; Kousho Wakae; Tasuku Honjo; Masamichi Muramatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

8.  APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.

Authors:  Hal P Bogerd; Heather L Wiegand; Brian P Doehle; Kira K Lueders; Bryan R Cullen
Journal:  Nucleic Acids Res       Date:  2006-01-10       Impact factor: 16.971

9.  Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.

Authors:  Valdimara C Vieira; Brandon Leonard; Elizabeth A White; Gabriel J Starrett; Nuri A Temiz; Laurel D Lorenz; Denis Lee; Marcelo A Soares; Paul F Lambert; Peter M Howley; Reuben S Harris
Journal:  mBio       Date:  2014-12-23       Impact factor: 7.867

10.  Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk.

Authors:  Mayumi Imahashi; Taisuke Izumi; Dai Watanabe; Junji Imamura; Kazuhiro Matsuoka; Hirotaka Ode; Takashi Masaoka; Kei Sato; Noriyo Kaneko; Seiichi Ichikawa; Yoshio Koyanagi; Akifumi Takaori-Kondo; Makoto Utsumi; Yoshiyuki Yokomaku; Takuma Shirasaka; Wataru Sugiura; Yasumasa Iwatani; Tomoki Naoe
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more
  208 in total

1.  Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.

Authors:  Zhigang Chen; Thomas L Eggerman; Alexander V Bocharov; Irina N Baranova; Tatyana G Vishnyakova; Roger Kurlander; Amy P Patterson
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

2.  Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.

Authors:  Qinyong Gu; Zeli Zhang; Lucía Cano Ortiz; Ana Cláudia Franco; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  APOBEC3A damages the cellular genome during DNA replication.

Authors:  Abby M Green; Sébastien Landry; Konstantin Budagyan; Daphne C Avgousti; Sophia Shalhout; Ashok S Bhagwat; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

4.  APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.

Authors:  Yiska Weisblum; Esther Oiknine-Djian; Zichria Zakay-Rones; Olesya Vorontsov; Ronit Haimov-Kochman; Yuval Nevo; David Stockheim; Simcha Yagel; Amos Panet; Dana G Wolf
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 5.  The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

Authors:  Abby M Green; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2019-09-13

6.  A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.

Authors:  Adam Z Cheng; Sofia N Moraes; Claire Attarian; Jaime Yockteng-Melgar; Matthew C Jarvis; Matteo Biolatti; Ganna Galitska; Valentina Dell'Oste; Lori Frappier; Craig J Bierle; Stephen A Rice; Reuben S Harris
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

7.  APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.

Authors:  Samantha J Ziegler; Yingxia Hu; Swapnil C Devarkar; Yong Xiong
Journal:  Biochemistry       Date:  2019-09-03       Impact factor: 3.162

Review 8.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

9.  Highly heterogeneous mutation rates in the hepatitis C virus genome.

Authors:  Ron Geller; Úrsula Estada; Joan B Peris; Iván Andreu; Juan-Vicente Bou; Raquel Garijo; José M Cuevas; Rosario Sabariegos; Antonio Mas; Rafael Sanjuán
Journal:  Nat Microbiol       Date:  2016-04-18       Impact factor: 17.745

10.  Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.